Literature DB >> 21424205

B-type natriuretic peptide increases after gastric bypass surgery and correlates with weight loss.

Eric M Changchien1, Shushmita Ahmed, Francesca Betti, Jennifer Higa, Kate Kiely, Tina Hernandez-Boussard, John Morton.   

Abstract

BACKGROUND: Coronary artery disease is the primary cause of death in the United States, with obesity as a leading preventable risk factor. Previous studies have established the beneficial effect of Roux-en-Y gastric bypass on both weight and cardiac risk factors. Further assessment of cardiac function may be accomplished using B-type natriuretic peptide (BNP), which has demonstrated clinical utility in diagnosing congestive heart failure. This study aimed to assess changes in BNP after intentional weight loss through gastric bypass surgery.
METHODS: Plasma volume, weight, and BNP were measured preoperatively and at 3, 6, and 12 months postoperatively for 101 consecutive patients undergoing laparoscopic gastric bypass surgery by a single surgeon in an academic medical setting. Outcomes were compared by matched t-test. Multivariable linear regression and Pearson's correlation were used to examine predictors of pro-B-type natriuretic peptide (NT-proBNP) concentration.
RESULTS: The concentration of BNP increased significantly from a mean preoperative level of 50.5 ng/l to postoperative levels of 73.9 ng/l at 3 months (P=0.013), 74.3 ng/l at 6 months (P<0.001), and 156.3 ng/l at 12 months (P<0.001). In addition, excess weight loss was the only statistically significant predictor of increased BNP concentration (odds ratio, 1.483; P<0.05).
CONCLUSION: Gastric bypass leads to significant excess weight loss and surprisingly increased BNP concentrations. Correlation of BNP increase with weight loss suggests an additional novel mechanism for surgically induced weight loss.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21424205     DOI: 10.1007/s00464-010-1565-1

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  23 in total

1.  Plasma brain natriuretic peptide and N-terminal proatrial natriuretic peptide levels in obese patients: a cause or result of hypertension?

Authors:  Junichi Minami; Toshio Nishikimi; Hiroaki Matsuoka
Journal:  Circulation       Date:  2004-08-17       Impact factor: 29.690

2.  Cardiac remodeling after substantial weight loss: a prospective cardiac magnetic resonance study after bariatric surgery.

Authors:  Rahul R Jhaveri; Kyle K Pond; Thomas H Hauser; Kraig V Kissinger; Lois Goepfert; Benjamin Schneider; Daniel B Jones; Warren J Manning
Journal:  Surg Obes Relat Dis       Date:  2009-02-25       Impact factor: 4.734

3.  The effect of surgical weight reduction on left ventricular structure and function in severe obesity.

Authors:  Chin-Feng Hsuan; Chih-Kun Huang; Jou-Wei Lin; Lung-Chun Lin; Thung-Lip Lee; Chi-Ming Tai; Wei-Hsian Yin; Wei-Kung Tseng; Kwan-Lih Hsu; Chau-Chung Wu
Journal:  Obesity (Silver Spring)       Date:  2010-03-18       Impact factor: 5.002

4.  Expression of natriuretic peptide receptors in human adipose and other tissues.

Authors:  R Sarzani; P Dessì-Fulgheri; V M Paci; E Espinosa; A Rappelli
Journal:  J Endocrinol Invest       Date:  1996-10       Impact factor: 4.256

Review 5.  Prognostic value of brain natriuretic peptide in noncardiac surgery: a meta-analysis.

Authors:  Alisdair D S Ryding; Saurabh Kumar; Angela M Worthington; David Burgess
Journal:  Anesthesiology       Date:  2009-08       Impact factor: 7.892

Review 6.  Natriuretic peptides.

Authors:  Lori B Daniels; Alan S Maisel
Journal:  J Am Coll Cardiol       Date:  2007-12-18       Impact factor: 24.094

7.  Impact of obesity on plasma natriuretic peptide levels.

Authors:  Thomas J Wang; Martin G Larson; Daniel Levy; Emelia J Benjamin; Eric P Leip; Peter W F Wilson; Ramachandran S Vasan
Journal:  Circulation       Date:  2004-02-10       Impact factor: 29.690

Review 8.  Understanding amino-terminal pro-B-type natriuretic peptide in obesity.

Authors:  Antoni Bayes-Genis; Christopher DeFilippi; James L Januzzi
Journal:  Am J Cardiol       Date:  2008-02-04       Impact factor: 2.778

9.  Effect of experimental obesity and subsequent weight reduction upon circulating atrial natriuretic peptide.

Authors:  D L Crandall; G D Ferraro; P Cervoni
Journal:  Proc Soc Exp Biol Med       Date:  1989-09

10.  Elevated adiponectin levels in patients with chronic heart failure: an independent predictor of mortality or a marker of cardiac cachexia?

Authors:  Turgay Celik; Halil Yaman
Journal:  Int J Cardiol       Date:  2009-03-23       Impact factor: 4.164

View more
  15 in total

Review 1.  Obesity and natriuretic peptides, BNP and NT-proBNP: mechanisms and diagnostic implications for heart failure.

Authors:  Chaitanya Madamanchi; Hassan Alhosaini; Arihiro Sumida; Marschall S Runge
Journal:  Int J Cardiol       Date:  2014-08-09       Impact factor: 4.164

2.  Cardiovascular Changes After Gastric Bypass Surgery: Involvement of Increased Secretions of Glucagon-Like Peptide-1 and Brain Natriuretic Peptide.

Authors:  Maria-Pia Gandolfini; Muriel Coupaye; Elodie Bouaziz; Monique Dehoux; David Hajage; Jean-Marc Lacorte; Séverine Ledoux
Journal:  Obes Surg       Date:  2015-10       Impact factor: 4.129

3.  The evaluation of brain natriuretic peptide changes and difficult airway predictors during perioperative period of pregnancy.

Authors:  G Basaranoglu; T Umutoglu; M Bakan; A Esen; S Ates; A Bacaksiz; Z Salihoglu
Journal:  Ir J Med Sci       Date:  2014-10-31       Impact factor: 1.568

4.  Gastric bypass surgery elevates NT-ProBNP levels.

Authors:  Niclas Abrahamsson; Britt Edén Engström; Magnus Sundbom; F Anders Karlsson
Journal:  Obes Surg       Date:  2013-09       Impact factor: 4.129

5.  Higher natriuretic peptide levels associate with a favorable adipose tissue distribution profile.

Authors:  Ian J Neeland; Benjamin R Winders; Colby R Ayers; Sandeep R Das; Alice Y Chang; Jarett D Berry; Amit Khera; Darren K McGuire; Gloria L Vega; James A de Lemos; Aslan T Turer
Journal:  J Am Coll Cardiol       Date:  2013-04-16       Impact factor: 24.094

Review 6.  Brown and Beige Adipose Tissue: Therapy for Obesity and Its Comorbidities?

Authors:  Anny Mulya; John P Kirwan
Journal:  Endocrinol Metab Clin North Am       Date:  2016-09       Impact factor: 4.741

7.  Effect of various weight loss interventions on serum NT-proBNP concentration in severe obese subjects without clinical manifest heart failure.

Authors:  Tim Hollstein; Kristina Schlicht; Laura Krause; Stefanie Hagen; Nathalie Rohmann; Dominik M Schulte; Kathrin Türk; Alexia Beckmann; Markus Ahrens; Andre Franke; Stefan Schreiber; Thomas Becker; Jan Beckmann; Matthias Laudes
Journal:  Sci Rep       Date:  2021-05-12       Impact factor: 4.379

8.  Activation of natriuretic peptides and the sympathetic nervous system following Roux-en-Y gastric bypass is associated with gonadal adipose tissues browning.

Authors:  Michael D Neinast; Aaron P Frank; Juliet F Zechner; Quanlin Li; Lavanya Vishvanath; Biff F Palmer; Vincent Aguirre; Rana K Gupta; Deborah J Clegg
Journal:  Mol Metab       Date:  2015-03-03       Impact factor: 7.422

Review 9.  The role of hormonal factors in weight loss and recidivism after bariatric surgery.

Authors:  S D Pedersen
Journal:  Gastroenterol Res Pract       Date:  2013-10-23       Impact factor: 2.260

10.  Cardiac natriuretic peptides in plasma increase after dietary induced weight loss in obesity.

Authors:  Caroline Kistorp; Henning Bliddal; Jens P Goetze; Robin Christensen; Jens Faber
Journal:  BMC Obes       Date:  2014-12-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.